The Neurogenetics and Genomic Medicine market is experiencing significant growth due to advancements in genomic technologies, increased understanding of genetic contributions to neurological disorders, and the rising demand for personalized medicine. This market encompasses genetic testing services, next-generation sequencing platforms, and therapies tailored to individual genetic profiles. Growing awareness of the genetic basis of neurological conditions, such as neurodegenerative disorders and epilepsy, fuels market expansion. Collaborations between genomics researchers, healthcare providers, and pharmaceutical companies contribute to ongoing research initiatives. North America and Europe lead the market, driven by robust healthcare infrastructures and research investments. The Asia-Pacific region shows promise with rising healthcare awareness and initiatives. The market is characterized by continuous technological innovation, precision medicine initiatives, and a focus on deciphering the genetic underpinnings of various neurological disorders.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
